210 publications
| Name | Date | Type | Actions |
|---|---|---|---|
Availability of the 2023 universal registration document On 24 April 2024, Vetoquinol filed its 2022 Universal Registration Document with the Autorité des Marchés Financiers (AMF) in ESEF (European Single Electronic Format). |
24/04/2024 | Public releases | |
Buyback programs - March 2024 Monthly communication regarding buyback programs |
04/04/2024 | Description of buyback programs | |
2023 ANNUAL RESULTS Annual sales: €529m (stable at constant exchange rates) |
20/03/2024 | Public releases | |
Buyback programs – January 2024 Monthly communication regarding buyback programs |
02/02/2024 | Description of buyback programs | |
Annual sales 2023: €529 million Annual Sales of Essential products: €313 million (up 4.5% at constant exchange rates) |
24/01/2024 | Public releases | |
Buyback programs - November 2023 Monthly communication regarding buyback programs |
04/12/2023 | Description of buyback programs | |
Buyback programs - december 2023 Monthly communication regarding buyback programs |
03/12/2023 | Description of buyback programs | |
Buyback programs - october 2023 Monthly communication regarding buyback programs |
06/11/2023 | Description of buyback programs | |
Sales 3rd quarter 2023: 136M€ The Vetoquinol Group posted sales of €136 million in Q3 2023, up +1.3% on a reported basis and +5.1% at constant exchange rates. Over the same period, Vetoquinol recorded a negative currency impact of -€5 million, linked to the Americas and Asia Pacific/Rest of World territories. |
26/10/2023 | Public releases | |
Buyback programs - September 2023 (french) Monthly communication regarding buyback programs |
04/10/2023 | Description of buyback programs |